Orphan Drugs, a successful regulation after all? Or just about to experience its pitfalls?
On December 5, 2018, the General Court ruled in favor of the European Commission in an action brought by Bristol-Myers Squibb Pharma (BMS...
Frantzeska Papadopoulou -
Saturday, January 05, 2019
Orphan Drugs, a successful regulation after all? Or just about to experience its pitfalls?
Reviewed by Frantzeska Papadopoulou
on
Saturday, January 05, 2019
Rating:
Reviewed by Frantzeska Papadopoulou
on
Saturday, January 05, 2019
Rating: